Molecular Pathology

Molecular Pathology

The Vancouver Prostate Centre's Molecular Pathology core facility offers clinical grade, high throughput analytical services with fast turnaround times. Our unique access to live human tumour tissues allows for identification of new tumour targets, validation of function, and the development of tumour models in our Functional Genomics core facility.

Cellular and Molecular Imaging Suite

The Cellular and Molecular Imaging Suite supports the use of state-of-the-art bright field, laser scanning and spinning disk confocal fluorescent microscopic imaging technologies for cellular and subcellular localization studies of molecules and pathways critical to prostate cancer cell growth and survival. These imaging systems are used to monitor cellular expression and localization of proteins, which enable studies of the role of these factors in regulation of tumour cell growth, survival and differentiation signalling pathways.

Bio-Repository – A Unique Research Resource

The Vancouver Prostate Centre has a tumour bank that contains well over 2000 prostate cancer specimens (both fresh frozen and paraffin embedded). This tumour bank has an integrated database that is overseen by a full-time coordinator, along with a full-time research pathologist and staff.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Fathers Day Walk Run 2019

Raymond James Father's Day Walk Run Fundraiser, June 16, 2019

The 21st Annual Raymond James Walk Run fundraiser for Prostate Cancer Foundation BC took place on Sunday June 16, 2019 in various locations across BC. The sponsorship page is still accepting donations;  click here to sponsor our Centre's team (opens in new window).

 

Employment

Work at the Vancouver Prostate Centre

Monday, July 8, 2019

Dr. Flannigan to lead clinical trial for scrotal pain treatment

Dr. Flannigan
Monday, June 3, 2019

Benefits Seen With Apalutamide Plus ADT in Metastatic Castration-Sensitive Prostate Cancer

Dr. Chi